Breaking News Instant updates and real-time market news.

ACRS

Aclaris Therapeutics

$13.31

0.16 (1.22%)

08:25
10/12/18
10/12
08:25
10/12/18
08:25

FDA Anesthetic & Analgesic Drug Products Advisory Committee to hold meeting

The Committee discusses AcelRx Pharmaceuticals' New Drug Application (NDA) 209128 Sufentanil Sublingual tablets for the management of moderate-to-severe acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate, in adult patients in a medically supervised setting. The committee will also be asked to discuss risk-benefit considerations and whether this product should be approved in the meeting being held at the FDA Silver Spring, MD offices on October 12 at 8 am. Webcast Link

  • 27

    Nov

ACRS Aclaris Therapeutics
$13.31

0.16 (1.22%)

03/28/18
LEER
03/28/18
INITIATION
Target $52
LEER
Outperform
Aclaris Therapeutics assumed with an Outperform at Leerink
Leerink analyst Etzer Darout assumed coverage of Aclaris Therapeutics with an Outperform rating and $52 price target. The company's lead program Eskata offers a new treatment option for patients with seborrheic keratosis with reduced risk of dyspigmentation and scarring, the analyst tells investors in a research note.
04/10/18
CANT
04/10/18
NO CHANGE
Target $50
CANT
Overweight
Aclaris insider buying underscores attractive valuation, says Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen highlights "meaningful" recent insider buying from executive officers at Aclaris Therapeutics, including, CEO Neal Walker, CFO Frank Ruffo and Chairman Stephen Tullman. Chen believes the stock purchases underscore her view that Aclaris shares are undervalued. The market underappreciates the commercial opportunity for Eskata, A-101 for warts, JAK for hair loss as well as vitiligo and the Confluence assets, Chen tells investors in a research note. She keeps an Overweight rating on Aclaris Therapeutics with a $50 price target.
07/17/18
CANT
07/17/18
NO CHANGE
CANT
Overweight
Aclaris offers best risk/reward of hair loss players, says Cantor Fitzgerald
The potential for JAK inhibitors to treat alopecia areata may be underappreciated by investors because the Street does not appear to be ascribing enough value to the opportunity, Cantor Fitzgerald analyst Louise Chen tells investors in a research note. Of the three companies she covers developing JAKs for hair loss, Aclaris Therapeutics (ACRS), Eli Lilly (LLY) and Pfizer (PFE), the analyst believes Aclaris offers the best risk/reward and greatest upside potential. The company has a market cap below $700M and two potential "shots on goal" for alopecia areata, Chen writes. She estimates combined peak sales of $1B-plus for both opportunities and keeps an Overweight rating on Aclaris. The physicians the analyst spoke to believe the company's JAKs for hair loss will work.
09/07/18
JEFF
09/07/18
NO CHANGE
Target $30
JEFF
Buy
Expectations for Aclaris Therapeutics' Eskata are low, says Jefferies
Jefferies analyst David Steinberg surveyed 50 physicians who treat a high volume of seborrheic keratosis patients to better understand their views on Aclaris Therapeutics' Eskata. Respondents indicated that 54% of their patients could potentially benefit from Eskata, Steinberg tells investors in a research note. Given that 83M Americans have some form of SK, the survey-derived peak sales estimate of $250M for Eskata "does not seem unreasonable," the analyst adds. He believe expectations for Eskata are low, "particularly considering the growing value" of Aclaris' late stage pipeline. Steinberg lowered his price target for the shares to $30 from $33 and keeps a Buy rating on Aclaris Therapeutics.

TODAY'S FREE FLY STORIES

DGX

Quest Diagnostics

$94.28

-7.25 (-7.14%)

10:45
10/23/18
10/23
10:45
10/23/18
10:45
Recommendations
Quest Diagnostics analyst commentary  »

Quest Diagnostics key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

VZ

Verizon

$56.74

1.78 (3.24%)

10:41
10/23/18
10/23
10:41
10/23/18
10:41
Recommendations
Verizon analyst commentary  »

Verizon more or less…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 12

    Nov

  • 13

    Nov

BAC

Bank of America

$26.40

-0.96 (-3.51%)

10:40
10/23/18
10/23
10:40
10/23/18
10:40
Options
BofA calls outpace puts 13:1 »

BofA calls outpace puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

GLT

Glatfelter

$18.20

-0.295 (-1.60%)

10:40
10/23/18
10/23
10:40
10/23/18
10:40
Hot Stocks
Glatfelter's Composite Fibers unit announces 7% price increase »

Glatfelter announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

10:40
10/23/18
10/23
10:40
10/23/18
10:40
General news
Fed Policy Outlook: the markets will look for any sign the FOMC is reacting »

Fed Policy Outlook: the…

RH

RH

$110.05

0.95 (0.87%)

, MO

Altria Group

$60.96

-0.35 (-0.57%)

10:35
10/23/18
10/23
10:35
10/23/18
10:35
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

RH

RH

$110.05

0.95 (0.87%)

MO

Altria Group

$60.96

-0.35 (-0.57%)

GRTS

Gritstone Oncology

$16.10

0.93 (6.13%)

CZR

Caesars

$8.98

-0.51 (-5.37%)

TEAM

Atlassian

$70.16

-2.46 (-3.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

EBAY

eBay

$27.72

-0.76 (-2.67%)

, DISH

Dish

$31.99

-2.67 (-7.70%)

10:35
10/23/18
10/23
10:35
10/23/18
10:35
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

EBAY

eBay

$27.72

-0.76 (-2.67%)

DISH

Dish

$31.99

-2.67 (-7.70%)

INN

Summit Hotel Properties

$11.12

-0.74 (-6.24%)

STAY

Extended Stay America

$16.28

-1.2 (-6.87%)

LBRT

Liberty Oilfield Services

$16.14

-2.18 (-11.90%)

MLCO

Melco Resorts & Entertainment

$16.91

-0.83 (-4.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 03

    Mar

VIA

Viacom

$36.01

-0.6 (-1.64%)

, VIAB

Viacom

$32.66

-0.34 (-1.03%)

10:35
10/23/18
10/23
10:35
10/23/18
10:35
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

VIA

Viacom

$36.01

-0.6 (-1.64%)

VIAB

Viacom

$32.66

-0.34 (-1.03%)

SNPS

Synopsys

$88.80

-0.07 (-0.08%)

CDNS

Cadence Design

$44.34

3.72 (9.16%)

PII

Polaris Industries

$86.99

-5.63 (-6.08%)

AMD

AMD

$24.35

-0.69 (-2.76%)

NXPI

NXP Semiconductors

$74.97

-1.5 (-1.96%)

CMG

Chipotle

$429.89

-1.36 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 01

    Nov

  • 06

    Dec

  • 13

    Dec

  • 12

    Mar

MGM

MGM Resorts

$24.84

-1.27 (-4.86%)

10:30
10/23/18
10/23
10:30
10/23/18
10:30
Options
Call spread in MGM as shares fall to 52-week lows »

Call spread in MGM as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

10:30
10/23/18
10/23
10:30
10/23/18
10:30
General news
U.S. equities rotated sharply lower »

U.S. equities rotated…

TSLA

Tesla

$275.35

14.32 (5.49%)

10:29
10/23/18
10/23
10:29
10/23/18
10:29
Hot Stocks
Tesla races as short-seller Citron reverses course, goes long »

Citron Research, best…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

TOT

Total

$58.38

-1.47 (-2.46%)

10:28
10/23/18
10/23
10:28
10/23/18
10:28
Hot Stocks
Total CEO justifies appearance at Saudi investment conference »

Total CEO Patrick…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
10/23/18
10/23
10:25
10/23/18
10:25
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

10:25
10/23/18
10/23
10:25
10/23/18
10:25
Conference/Events
The FCC to hold a meeting »

Open Commission Meeting…

JBLU

JetBlue

$16.59

0.02 (0.12%)

10:20
10/23/18
10/23
10:20
10/23/18
10:20
Hot Stocks
Breaking Hot Stocks news story on JetBlue »

JetBlue says expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ARNC

Arconic

$20.73

-0.72 (-3.36%)

10:20
10/23/18
10/23
10:20
10/23/18
10:20
Options
Active trading in Arconic call options including a notable three-way spread »

Active trading in Arconic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

JBLU

JetBlue

$16.56

-0.01 (-0.06%)

10:18
10/23/18
10/23
10:18
10/23/18
10:18
Hot Stocks
JetBlue says Q4 booking trends 'encouraging' »

Says executing plan to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
10/23/18
10/23
10:17
10/23/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
10/23/18
10/23
10:16
10/23/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$44.84

-0.91 (-1.99%)

10:15
10/23/18
10/23
10:15
10/23/18
10:15
Options
Cisco put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

10:15
10/23/18
10/23
10:15
10/23/18
10:15
General news
U.S. Richmond Fed's manufacturing index dove 14 points to 15 in October »

U.S. Richmond Fed's…

10:15
10/23/18
10/23
10:15
10/23/18
10:15
General news
Treasury Action: yields extended their retreat »

Treasury Action: yields…

CLF

Cleveland-Cliffs

$10.96

-0.37 (-3.27%)

10:08
10/23/18
10/23
10:08
10/23/18
10:08
Recommendations
Cleveland-Cliffs analyst commentary  »

Vertical sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$96.98

-0.16 (-0.16%)

, SPWR

SunPower

$6.64

-0.1 (-1.48%)

10:08
10/23/18
10/23
10:08
10/23/18
10:08
Hot Stocks
Walmart, SunPower announce 23-megawatt solar agreement »

Walmart (WMT) announced…

WMT

Walmart

$96.98

-0.16 (-0.16%)

SPWR

SunPower

$6.64

-0.1 (-1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 15

    Nov

REV

Revlon

$24.60

-0.09 (-0.36%)

10:06
10/23/18
10/23
10:06
10/23/18
10:06
Periodicals
Mox Reports repeats long call on Revlon »

MoxReports tweeted:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.